BioSpace News Archive

Horizon Therapeutics plc to Host Virtual R&D Day on Sept. 29, 2021

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it will host a virtual R&D Day for investors and analysts on Wednesday, Sept. 29, 2021 at 8 a.m. CT.

June 30, 2021
·
1 min read
Biotech Bay

Oncology Pharma, Inc. is Entering Into the Next Phase of its Growth and Expansion Phase

Oncology Pharma Inc. is developing a program to establish the use of its license utilizing NR2F6 agonists and antagonists coupled with the proprietary drug delivery systems in the treatment of various disorders including human pancreatic cancer and colon cancer.

June 30, 2021
·
3 min read
FDA

LEXEO Therapeutics Receives Rare Pediatric Disease Designation and Orphan Drug Designation for LX2006 for the Treatment of Friedreich’s Ataxia

LEXEO Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation and Orphan Drug designation to LX2006 for the treatment of Friedreich’s ataxia (FA).

June 30, 2021
·
3 min read
Pharm Country

Zoetis to Host Webcast and Conference Call on Second Quarter 2021 Financial Results

Zoetis Inc . (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Aug. 5, 2021.

June 30, 2021
·
1 min read
Pharm Country

Mitsubishi Tanabe Pharma America Announces EXSERVAN™ (riluzole) is Now Available in the U.S. for the Treatment of ALS

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that EXSERVAN™ (riluzole), the first oral film formulation of riluzole, is now available in the U.S. for the treatment of amyotrophic lateral sclerosis (ALS).

June 30, 2021
·
7 min read
Nemaura Medical Announces Presentation on its Licensed Why WAIT Program During the American Diabetes Association 81st Annual Scientific Sessions

Nemaura Medical, Inc. today announces a presentation referring to its licensed Why WAIT ® program at the American Diabetes Association’s 81st Annual Scientific Sessions.

June 30, 2021
·
5 min read
Drug Development

International Stem Cell Corporation Announces Successful Completion of Its Phase 1 Clinical Trial in Parkinson’s Disease

International Stem Cell Corporation announced today successful completion of its dose escalating phase 1 clinical trial.

June 30, 2021
·
7 min read
Deals

Safeguard Medical Acquires PerSys Medical Bringing the Broadest Portfolio of Options for Life-Saving Medical Equipment, Technologies, and Services to First Responders

Safeguard Medical, a global leader in innovative emergency medical technologies and specialized training for first responders, announced today that it is acquiring PerSys Medical.

June 30, 2021
·
3 min read
BioCapital

CEL-SCI to Conduct Investor Call Regarding Phase 3 Results Following Annual Shareholder Meeting on July 1, 2021

CEL-SCI Corporation (NYSE American: CVM) today announced that right after its previously scheduled Annual Shareholder Meeting, on July 1, 2021 at 10:00 am EDT, the Company will discuss its Phase 3 head and neck cancer trial results at the conclusion of the Annual Shareholder Meeting.

June 30, 2021
·
4 min read
Lone Star Bio

Texas Children’s Hospital surgeons perform 100th pioneering fetoscopic procedure to treat spina bifida

Surgeons who pioneered an in-utero procedure that has improved the outcomes of children with spina bifida, and their mothers who underwent the fetal surgery, performed the 100th surgery of its kind Tuesday at Texas Children’s Fetal Center.

June 30, 2021
·
7 min read